Short interest in Iterum Therapeutics PLC (NASDAQ:ITRM) decreased during the last reporting period, falling from 443.60K to 222.83K. This put 1.01% of the company's publicly available shares short.

Short interest for Iterum Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Iterum Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 246.80K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.